Anti SARS-CoV-2 seroprevalence in Zanzibar in 2021 before the Omicron wave
- PMID: 35814620
- PMCID: PMC9251954
- DOI: 10.1016/j.ijregi.2022.06.007
Anti SARS-CoV-2 seroprevalence in Zanzibar in 2021 before the Omicron wave
Abstract
Objectives: For Tanzania, including Zanzibar, the development of the COVID-19 pandemic has remained unclear since the reporting of cases was suspended during 2020/21. Our study was the first to analyze data on COVID-19 seroprevalence in the Zanzibari population before the Omicron variant wave began in late 2021.
Design: During August through October 2021, representative cross-sectional data were collected from randomly selected households in 120 wards of the two main islands, Unguja and Pemba. Participants voluntarily provided blood samples to test their sera for antibodies against SARS-CoV-2 using a semiquantitative enzyme-linked immunosorbent assay (ELISA).
Results: 58.9% of the 2051 sera analysed were positive, without significant differences between Unguja and Pemba or between rural and urban areas. The results were in agreement with observations from other sub-Saharan African countries.
Conclusions: The antibody levels observed were most likely due to previous infections with SARS-CoV-2, since vaccination was generally not available before the survey. Therefore, this study offers the first insights into how many Zanzibari had COVID-19 before the Omicron variant emerged. Furthermore, it provides an appropriate basis for a follow-up survey addressing how this seroprevalence has influenced susceptibility to the Omicron variants, given the use of harmonized methodologies.
Keywords: COVID-19; SARS-CoV-2; Tanzania; cross-sectional; epidemiology; population-based.
© 2022 The Author(s).
Conflict of interest statement
All authors declare no conflicts of interest regarding the publication of this study.
Similar articles
-
SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021.BMC Med. 2021 Nov 19;19(1):303. doi: 10.1186/s12916-021-02187-y. BMC Med. 2021. PMID: 34794434 Free PMC article.
-
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study.Lancet Reg Health Eur. 2023 Jan;24:100547. doi: 10.1016/j.lanepe.2022.100547. Epub 2022 Dec 1. Lancet Reg Health Eur. 2023. PMID: 36474728 Free PMC article.
-
Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults.BMC Infect Dis. 2024 Aug 20;24(1):841. doi: 10.1186/s12879-024-09670-w. BMC Infect Dis. 2024. PMID: 39164637 Free PMC article.
-
A cross-sectional study of SARS-CoV-2 antibodies among healthcare workers in a tertiary care hospital in Taiwan: implications for protection against the Omicron variants.BMC Infect Dis. 2024 May 27;24(1):529. doi: 10.1186/s12879-024-09411-z. BMC Infect Dis. 2024. PMID: 38802771 Free PMC article.
-
Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.BMC Infect Dis. 2023 Jun 26;23(1):432. doi: 10.1186/s12879-023-08328-3. BMC Infect Dis. 2023. PMID: 37365490 Free PMC article.
Cited by
-
Evaluation of a surrogate virus neutralization assay for detecting neutralizing antibodies against SARS-CoV-2 in an African population.Biol Methods Protoc. 2024 Dec 23;10(1):bpae095. doi: 10.1093/biomethods/bpae095. eCollection 2025. Biol Methods Protoc. 2024. PMID: 39866376 Free PMC article.
-
High Seroprevalence of SARS-CoV-2 in Mwanza, Northwestern Tanzania: A Population-Based Survey.Int J Environ Res Public Health. 2022 Sep 16;19(18):11664. doi: 10.3390/ijerph191811664. Int J Environ Res Public Health. 2022. PMID: 36141938 Free PMC article.
-
Humoral Immune Responses following COVID-19 Vaccinations among Adults in Tanzania.Vaccines (Basel). 2023 Dec 23;12(1):22. doi: 10.3390/vaccines12010022. Vaccines (Basel). 2023. PMID: 38250835 Free PMC article.
-
High anti-SARS-CoV-2 seroprevalence among unvaccinated mother-child pairs from a rural setting in north-eastern Tanzania during the second wave of COVID-19.IJID Reg. 2023 Mar;6:48-57. doi: 10.1016/j.ijregi.2022.11.011. Epub 2022 Nov 28. IJID Reg. 2023. PMID: 36466214 Free PMC article.
-
Seroprevalence of SARS-CoV-2 antibodies in Republic of Congo, February 2022.Epidemiol Infect. 2023 Sep 11;151:e162. doi: 10.1017/S0950268823001425. Epidemiol Infect. 2023. PMID: 37800463 Free PMC article.
References
-
- Centers for Disease Control and Prevention. What COVID-19 seroprevalence surveys can tell us. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/seroprevalance-surv..., 2020 (visited April 18, 2022)
-
- Lewis HC, Ware H, Whelan M, Subissi L, Li Z, Ma X, et al. SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021; medRχiv preprint 2022; doi: 10.1101/2022.02.14.22270934 (visited April 18, 2022) - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous